Sugarcone Biotech LLC is the premier immuno-oncology strategic consulting and investment firm. Our success rate in launching, building and creating value across diverse immune oncology companies is stunning. Join founder Paul Rennert at the CRI-CIMT-EATI-AACR sponsored conference, Cancer Immunotherapy: Translating Science Into Survival, to explore ways that we can add value to your company and investments.
Paul will be onsite at the Times Square Sheraton September 16 – 19.
Email rennertp@sugarconebiotech.com or text/call 1-508-282-6370 to arrange a meeting.
see you in NYC –
